Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
146321
Video_2_Ex vivo Demonstration of Functional Deficiencies in Popliteal Lymphatic Vessels From TNF-Transgenic Mice With Inflammatory Arthritis.MP4
Published 2021“…The PLVs were harvested and cannulated for ex vivo functional analysis over a relatively wide range of hydrostatic pressures (0.5–10 cmH<sub>2</sub>O) to quantify the end diastolic diameter (EDD), tone, amplitude (AMP), ejection fraction (EF), contraction frequency (FREQ), and fractional pump flow (FPF) with or without NOS inhibitors Data were analyzed using repeated measures two-way ANOVA with Bonferroni’s post hoc test.…”
-
146322
Video_1_Ex vivo Demonstration of Functional Deficiencies in Popliteal Lymphatic Vessels From TNF-Transgenic Mice With Inflammatory Arthritis.MP4
Published 2021“…The PLVs were harvested and cannulated for ex vivo functional analysis over a relatively wide range of hydrostatic pressures (0.5–10 cmH<sub>2</sub>O) to quantify the end diastolic diameter (EDD), tone, amplitude (AMP), ejection fraction (EF), contraction frequency (FREQ), and fractional pump flow (FPF) with or without NOS inhibitors Data were analyzed using repeated measures two-way ANOVA with Bonferroni’s post hoc test.…”
-
146323
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes: Supplementary materials
Published 2022“…Hypothetical efficacy profiles were defined</p> <p>affecting resolution (100%-increase), fibrosis improvement (100% increase), or fibrosis worsening (50%</p> <p>decrease). Results: For the SoC, 10-year LRC rates increased with baseline fibrosis stage (F1: 3.0%; F2:</p> <p>9.8%; F3: 27.2%; F4/CC: 64.9%). …”
-
146324
Fine particulate matter estimated by mathematical model and hospitalizations for pneumonia and asthma in children
Published 2018“…Conclusions: Exposure to PM2.5 was associated with hospitalizations for pneumonia and asthma in children younger than 10 years of age, showing the role of fine particulate matter in child health and providing subsidies for the implementation of preventive measures to decrease these outcomes.…”
-
146325
DataSheet1_Acute exercise mobilizes CD8+ cytotoxic T cells and NK cells in lymphoma patients.docx
Published 2023“…Three had Hodgkin and four non-Hodgkin lymphoma, one was female, and their mean age was 51. Patients underwent a 10-min acute exercise on a bicycle ergometer at moderate exercise intensity. …”
-
146326
Table_2_Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.docx
Published 2020“…One of the main problems related to this disease is the emergence of severe clinical forms with a lethality of 5–20%, even while under specific treatment. …”
-
146327
Table_1_Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.docx
Published 2020“…One of the main problems related to this disease is the emergence of severe clinical forms with a lethality of 5–20%, even while under specific treatment. …”
-
146328
Image_1_Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.TIF
Published 2020“…One of the main problems related to this disease is the emergence of severe clinical forms with a lethality of 5–20%, even while under specific treatment. …”
-
146329
Trajectory classifier robustness across neural population sizes during SCT.
Published 2019“…<p><b>A</b>. SVM classifier performance (mean ± SD of percent of correct classifications) for target interval (five instructed intervals) during the SCT task based on the neural trajectory computed from different population sizes. …”
-
146330
-
146331
-
146332
-
146333
-
146334
Supplementary Material for: Course of duration and trigger factors of vertigo attacks in patients with benign recurrent vertigo, Menière’s disease or vestibular migraine
Published 2023“…Introduction: Benign Recurrent Vertigo (BRV), Menière's Disease (MD) and Vestibular Migraine (VM) show many similarities with regard to the course of vertigo attacks and clinical features. In this paper we elaborate on the decreasing frequency of vertigo attacks observed in a previous study from our group by exploring changes in the duration and trigger factors of vertigo attacks in patients with BRV, MD or VM. …”
-
146335
Integrative Approach Detected Association between Genetic Variants of microRNA Binding Sites of TLRs Pathway Genes and OSCC Susceptibility in Chinese Han Population
Published 2014“…<div><p>Oral squamous cell carcinoma (OSCC) is a leading malignancy worldwide; the overall 5-year survival rate is approximately 50%. A variety of proteins in Toll-like receptors (TLRs) pathway have been related with the risk of OSCC. …”
-
146336
Image_6_Streptococcus mutans Secreted Products Inhibit Candida albicans Induced Oral Candidiasis.TIFF
Published 2020“…Active S. mutans UA159 supernatant filtrate components were extracted via liquid-liquid partition and fractionated on a C-18 silica column to resolve S. mutans fraction 1 (SM-F1) and fraction 2 (SM-F2). We found anti-biofilm activity for both SM-F1 and SM-F2 in a dose dependent manner and fungal growth was reduced by 2.59 and 5.98 log for SM-F1 and SM-F2, respectively. …”
-
146337
Image_2_Streptococcus mutans Secreted Products Inhibit Candida albicans Induced Oral Candidiasis.JPEG
Published 2020“…Active S. mutans UA159 supernatant filtrate components were extracted via liquid-liquid partition and fractionated on a C-18 silica column to resolve S. mutans fraction 1 (SM-F1) and fraction 2 (SM-F2). We found anti-biofilm activity for both SM-F1 and SM-F2 in a dose dependent manner and fungal growth was reduced by 2.59 and 5.98 log for SM-F1 and SM-F2, respectively. …”
-
146338
Image_4_Streptococcus mutans Secreted Products Inhibit Candida albicans Induced Oral Candidiasis.JPEG
Published 2020“…Active S. mutans UA159 supernatant filtrate components were extracted via liquid-liquid partition and fractionated on a C-18 silica column to resolve S. mutans fraction 1 (SM-F1) and fraction 2 (SM-F2). We found anti-biofilm activity for both SM-F1 and SM-F2 in a dose dependent manner and fungal growth was reduced by 2.59 and 5.98 log for SM-F1 and SM-F2, respectively. …”
-
146339
Image_3_Streptococcus mutans Secreted Products Inhibit Candida albicans Induced Oral Candidiasis.PNG
Published 2020“…Active S. mutans UA159 supernatant filtrate components were extracted via liquid-liquid partition and fractionated on a C-18 silica column to resolve S. mutans fraction 1 (SM-F1) and fraction 2 (SM-F2). We found anti-biofilm activity for both SM-F1 and SM-F2 in a dose dependent manner and fungal growth was reduced by 2.59 and 5.98 log for SM-F1 and SM-F2, respectively. …”
-
146340
Image_1_Streptococcus mutans Secreted Products Inhibit Candida albicans Induced Oral Candidiasis.PNG
Published 2020“…Active S. mutans UA159 supernatant filtrate components were extracted via liquid-liquid partition and fractionated on a C-18 silica column to resolve S. mutans fraction 1 (SM-F1) and fraction 2 (SM-F2). We found anti-biofilm activity for both SM-F1 and SM-F2 in a dose dependent manner and fungal growth was reduced by 2.59 and 5.98 log for SM-F1 and SM-F2, respectively. …”